About Grafotas 25mg Capsule
Get unrivaled protection against organ rejection with affordable Grafotas 25mg Capsule-your world-class solution for immunosuppression. Each off-white to light yellow capsule, containing 25mg of tacrolimus, delivers unassailable efficacy for kidney, liver, or heart transplant patients. Marketed by Intas Pharmaceuticals Ltd. and WHO-GMP certified, this vital medication should be taken strictly as prescribed. Side effects may include tremors, hypertension, or increased infection risk, so regular monitoring is essential. Grab yours today, but always under prescription and expert supervision for optimal safety and benefit.
Exceptional Features and Usage Details
Grafotas 25mg Capsule is specifically designed for oral application and is suitable for adult transplant patients requiring immunosuppressive therapy. Its usage type is prescription-based, ensuring safety and effectiveness. The site of application is strictly oral, and each capsule should be swallowed whole with water-never chewed or crushed. The medicine comes in a secure blister pack, with a recommended storage below 25C to maintain potency and integrity.
Certifications, Policy, and Shipping Information
Grafotas 25mg Capsule is proudly WHO-GMP certified, reflecting superb quality standards. Sample policies can be arranged for bulk buyers, with flexible terms for traders, exporters, suppliers, and wholesalers. Handover and drop-off occur at major ports across India, and orders are swiftly shipped following confirmation-ensuring timely delivery. The product is sealed in robust packaging (10 x 10 capsules/box) and retains its efficacy for up to 2 years from manufacturing date.
FAQ's of Grafotas 25mg Capsule:
Q: How should Grafotas 25mg Capsule be administered?
A: Grafotas 25mg Capsule should be taken orally, exactly as prescribed by your healthcare provider. Swallow the capsule whole with water; do not chew or crush it.
Q: What are the main benefits of using Grafotas 25mg Capsule?
A: The main benefit is its world-class effectiveness in preventing organ rejection after kidney, liver, or heart transplants, helping ensure long-term organ survival.
Q: When should kidney and liver function be monitored during Grafotas therapy?
A: Kidney and liver function should be monitored regularly throughout treatment, as directed by your healthcare provider, to detect any potential side effects early.
Q: Where is Grafotas 25mg Capsule produced and who markets it?
A: Grafotas 25mg Capsule is produced in India and is marketed by Intas Pharmaceuticals Ltd., renowned for reliable and certified pharmaceutical products.
Q: What is the process for shipping Grafotas 25mg Capsules to buyers?
A: After order confirmation, products are handed over at designated ports, carefully packaged, and shipped rapidly to ensure they reach buyers in optimal condition.
Q: What precautions should be taken before starting Grafotas 25mg Capsule?
A: Ensure you are not hypersensitive to tacrolimus or other macrolides. Always use this medicine strictly under medical supervision and adhere to prescribed dosage and monitoring schedules.